Milestone Scientific (MLSS) Income from Non-Controlling Interests (2015 - 2023)
Milestone Scientific's (MLSS) quarterly Income from Non-Controlling Interests came in at -$17856.0 in Q4 2023, down 40.54% year-on-year from -$30031.8 in Q4 2022, and down 82.0% quarter-over-quarter from -$9811.0 in Q3 2023.
Milestone Scientific (MLSS) Income from Non-Controlling Interests (2015 - 2023) Analysis & Trends
Milestone Scientific has disclosed Income from Non-Controlling Interests across 9 years of filings, most recently posting -$17856.0 for Q4 2023.
- Income from Non-Controlling Interests for Q4 2023 came in at -$17856.0, down 40.54% year-over-year; the trailing twelve-month figure through Sep 2024 was -$17856.0 (up 61.76% YoY), and the FY2023 annual result was -$51843.0, up 22.32% from the prior year.
- Income from Non-Controlling Interests came in at -$17856.0 for Q4 2023 at Milestone Scientific, down from -$9811.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of -$9811.0 in Q3 2023 to a low of -$22848.0 in Q2 2022.
- The 5-year median for Income from Non-Controlling Interests is -$12839.5 (2019), against an average of -$14205.2.
- Peak annual rise in Income from Non-Controlling Interests reached 89.7% in 2019, while the deepest fall reached 70.99% in 2019.
- Milestone Scientific's Income from Non-Controlling Interests stood at -$20529.0 in 2019, then grew by 21.88% to -$16038.0 in 2020, then decreased by 3.35% to -$16575.0 in 2021, then grew by 23.35% to -$12705.0 in 2022, then plunged by 40.54% to -$17856.0 in 2023.
- The last three Income from Non-Controlling Interests figures came in at -$17856.0 (Q4 2023), -$9811.0 (Q3 2023), and -$12511.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 5.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 105.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Milestone Scientific | 28.92 Mn | 27.73 Mn | 1.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -17,856.00 |
| Sep 30, 2023 | -9,811.00 |
| Jun 30, 2023 | -12,511.00 |
| Mar 31, 2023 | -11,665.00 |
| Dec 31, 2022 | -12,705.00 |
| Sep 30, 2022 | -13,680.00 |
| Jun 30, 2022 | -22,848.00 |
| Mar 31, 2022 | -17,502.00 |
| Dec 31, 2021 | -16,575.00 |
| Sep 30, 2021 | -12,227.00 |
| Jun 30, 2021 | -16,325.00 |
| Mar 31, 2021 | -12,988.00 |
| Dec 31, 2020 | -16,038.00 |
| Sep 30, 2020 | -11,025.00 |
| Jun 30, 2020 | -11,738.00 |
| Mar 31, 2020 | -12,738.00 |
| Dec 31, 2019 | -20,529.00 |
| Sep 30, 2019 | -12,941.00 |
| Jun 30, 2019 | -11,959.00 |
| Mar 31, 2019 | -10,443.00 |